Literature DB >> 18350629

Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients.

Mohammad-K Tarzamni1, Mohammad-H Somi, Sara Farhang, Morteza Jalilvand.   

Abstract

AIM: To evaluate portal hypertension parameters in liver cirrhosis patients with and without esophageal varices (EV).
METHODS: A cohort of patients with biopsy confirmed liver cirrhosis was investigated endoscopically and with color Doppler ultrasonography as a possible non-invasive predictive tool. The relationship between portal hemodynamics and the presence and size of EV was evaluated using uni- and multivariate approaches.
RESULTS: Eighty five consecutive cirrhotic patients (43 men and 42 women) were enrolled. Mean age (+/- SD) was 47.5 (+/- 15.9). Portal vein diameter (13.88 +/- 2.42 vs 12.00 +/- 1.69, P < 0.0005) and liver vascular index (8.31 +/- 2.72 vs 17.8 +/- 6.28, P < 0.0005) were found to be significantly higher in patients with EV irrespective of size and in patients with large varices (14.54 +/- 1.48 vs 13.24 +/- 2.55, P < 0.05 and 6.45 +/- 2.78 vs 10.96 +/- 5.05, P < 0.0005, respectively), while portal vein flow velocity (13.25 +/- 3.66 vs 20.25 +/- 5.05, P < 0.0005), congestion index (CI) (0.11 +/- 0.03 vs 0.06 +/- 0.03, P < 0.0005), portal hypertensive index (2.62 +/- 0.79 vs 1.33 +/- 0.53, P < 0.0005), and hepatic (0.73 +/- 0.07 vs 0.66 +/- 0.07, P < 0.001) and splenic artery resistance index (RI) (0.73 +/- 0.06 vs 0.62 +/- 0.08, P < 0.0005) were significantly lower. A logistic regression model confirmed spleen size (P = 0.002, AUC 0.72) and portal hypertensive index (P = 0.040, AUC 0.79) as independent predictors for the occurrence of large esophageal varices (LEV).
CONCLUSION: Our data suggest two independent situations for beginning endoscopic evaluation of compensated cirrhotic patients: Portal hypertensive index > 2.08 and spleen size > 15.05 cm. These factors may help identifying patients with a low probability of LEV who may not need upper gastrointestinal endoscopy.

Entities:  

Mesh:

Year:  2008        PMID: 18350629      PMCID: PMC2700414          DOI: 10.3748/wjg.14.1898

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Bleeding esophageal varices. How to treat this dreaded complication of portal hypertension.

Authors:  A M Hegab; V A Luketic
Journal:  Postgrad Med       Date:  2001-02       Impact factor: 3.840

Review 2.  Variceal bleeding and portal hypertension: still a therapeutic challenge?

Authors:  S Seewald; U Seitz; A M Yang; N Soehendra
Journal:  Endoscopy       Date:  2001-02       Impact factor: 10.093

3.  Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?

Authors:  B Bressler; R Pinto; D El-Ashry; E J Heathcote
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Analysis of patients listed for liver transplantation in Shiraz, Iran.

Authors:  Mehdi Saberifiroozi; Ali Reza Serati; Seyed Ali Malekhosseini; Heshmatollah Salahi; Ali Bahador; Kamran Bagheri Lankarani; Seyed Ali Taghavi; Mahvash Alizadeh; Mohammad Reza Fattahi; Najaf Dehbashi; Siavash Gholami
Journal:  Indian J Gastroenterol       Date:  2006 Jan-Feb

5.  Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index.

Authors:  C Merkel; M Zoli; S Siringo; H van Buuren; D Magalotti; P Angeli; D Sacerdoti; L Bolondi; A Gatta
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

6.  Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound.

Authors:  Feng-Hua Li; Jing Hao; Jian-Guo Xia; Hong-Li Li; Hua Fang
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

7.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.

Authors:  E Giannini; F Botta; P Borro; D Risso; P Romagnoli; A Fasoli; M R Mele; E Testa; C Mansi; V Savarino; R Testa
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

9.  Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone.

Authors:  E Christensen; L Fauerholdt; P Schlichting; E Juhl; H Poulsen; N Tygstrup
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

10.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more
  5 in total

1.  Non-invasive assessment of fibrosis using color Doppler ultrasound in patients with hepatitis C virus in the Amazon rainforest, Brazil.

Authors:  Jorge Leão; Marianna Brock; Márcia Castilho; André Scariot; Ana Scariot; Wornei Braga
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Portal vein Doppler: a tool for non-invasive prediction of esophageal varices in cirrhosis.

Authors:  Minal Shastri; Sujay Kulkarni; Rushad Patell; Sarfaraz Jasdanwala
Journal:  J Clin Diagn Res       Date:  2014-07-20

Review 3.  Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review.

Authors:  Enrico Maria Zardi; Francesco Maria Di Matteo; Claudio Maurizio Pacella; Arun J Sanyal
Journal:  Ann Med       Date:  2013-12-16       Impact factor: 4.709

4.  Non-invasive prediction of esophageal varices: is it possible?

Authors:  Konstantinos C Thomopoulos
Journal:  Saudi J Gastroenterol       Date:  2011 Jan-Feb       Impact factor: 2.485

5.  Screening of Esophageal Varices by Noninvasive Means in Chronic Liver Disease.

Authors:  Enayet Hossain; Ferdaus Ahammed; Satyajit K Saha; Syed A Foez; Mohammad A Rahim; Sheikh M Noor-E-Alam; Abu S Abdullah
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.